Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
07/2003
07/16/2003EP1326892A2 Compositions that inhibit proliferation of cancer cells
07/16/2003EP1326839A2 Recombinant adenovirus vectors that are replication-competent in tert-expressing cells
07/16/2003EP1326654A2 Methods and compositions for tissue regeneration
07/16/2003EP1326630A2 Use of glp-1 and glp-2 peptides
07/16/2003EP1326622A1 Compositions and methods for treatment of multiple myeloma
07/16/2003EP1079772A4 Corporal tissue penile reconstruction
07/16/2003EP0743856B1 Antigen-based heteropolymers for treating autoimmune diseases
07/16/2003CN1430675A Use of baculovirus vectors in gene therapy
07/16/2003CN1430626A Sheep lice Bobicola ovis allergen treatment
07/16/2003CN1430518A Use of lactobacillus casei in immunostimulatory peptides
07/16/2003CN1429616A New preparation of compound Chinese medicine for treating osteoarthritis and its preparation method
07/16/2003CN1429615A Chinese medicine for treating prostatitis
07/16/2003CN1429612A Thirty-six ingredients capsule for treating diabetes
07/16/2003CN1429605A Drug composition for preventing and treating prospermia and/or sexual excitation hypersensitivity
07/16/2003CN1429603A Medicine for treating stomach disease
07/16/2003CN1429579A Massaging cream for relaxing muscles and tendons and its preparation method
07/16/2003CN1429572A Chinese patent drug for treating diabetes
07/16/2003CN1429562A Chinese medicine for treating tympanitis
07/16/2003CN1429561A Non-operation method of constructing human/goat mosaic
07/16/2003CN1429556A Muscle strong agent and anti-inflammatory agent
07/16/2003CN1429552A Medical use of 11,11'-dideoxy wotixilin
07/16/2003CN1114690C Papilloma pseudovirus and process for preparing same
07/16/2003CN1114618C Trivalent chromium compound, its milk product and making process
07/16/2003CN1114442C Burns treating ointment
07/16/2003CN1114441C Compound tree peony injection
07/16/2003CN1114439C Medicine for treating dermopathy and preparing process thereof
07/16/2003CN1114437C Medicated wine
07/16/2003CN1114431C Modicine for treating atrophic gastritis and its preparing process
07/16/2003CN1114430C Medicine for treating thrombus disease
07/16/2003CN1114425C Chinese patent medicine for treating coronary heart disease and hypertension
07/16/2003CN1114422C Anti-cancer Chinese-medicinal pill
07/16/2003CN1114420C Medicine for treating intractable ischias and chronic lumbocrural pain and its preparing process
07/16/2003CN1114418C Medicine for treating rheumatism and aploplexy and its preparation process
07/16/2003CN1114410C Product of heat treatment of uronic acid, food, drink and drug containing the product
07/16/2003CN1114395C Skin-care ecological nutritive cream of forest frog's oviduct fat and its preparing process
07/15/2003US6593463 Malarial merozite surface protein (MSP); modified nucleic acid sequence; AT content has been reduced by replacing codons with mammary gland preferred codons; useful in development of a vaccine against malaria
07/15/2003US6593309 Contacting a sample containing sperm with a solution comprising a polysaccharide containing arabinose, galactose and/or hexuronic acid (PCAGH) to form a mixture, wherein the PCAGH is not arabinogalactan; separating sperm from the sample
07/15/2003US6593295 Long lasting insulinotropic peptides
07/15/2003US6593132 Nucleotide sequences coding polypeptide for use in the treatment of cancer
07/15/2003US6593096 Determining the level of interferon- gamma and CD28 marker in blood; Bacille Calmette-Guerin; immunocompetence
07/15/2003US6592886 Producing stable cross-linked alginate gel by binding surplus cations with anions
07/15/2003US6592874 Togavirus capsid particle that does not contain genomic or RNA vector replicon nucleic acids
07/15/2003US6592868 Produced by hybridoma having ATCC Accession Number HB 10916
07/15/2003US6592864 Treating pulmonary hypertension; administering transfected cells containing an expressible transgene directly into pulmonary system
07/15/2003US6592618 In vitro modification of cardiac valvular xenografts
07/10/2003WO2003056019A1 Method of transducing es cells
07/10/2003WO2003056012A1 A system for stable expression of sirnas in mammalian cells
07/10/2003WO2003055992A2 A method for the establishment of a pluripotent human blastocyst-derived stem cell line
07/10/2003WO2003055990A2 Method for culturing and expansion of mammalian undifferentiated epidermal keratinocytes exhibiting stem cell characteristics
07/10/2003WO2003055989A2 Cellular compositions and methods of making and using them
07/10/2003WO2003055987A1 Novel lactobacillus sp. strain and use thereof
07/10/2003WO2003055984A1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
07/10/2003WO2003055983A2 Targeted retrograde gene delivery to motor neurons
07/10/2003WO2003055980A2 Il-17 like molecules and uses thereof
07/10/2003WO2003055915A2 Human netrin receptor and uses thereof
07/10/2003WO2003055913A2 Secreted protein
07/10/2003WO2003055912A2 Secreted proteins
07/10/2003WO2003055529A1 Dna vaccine for periodontal disease
07/10/2003WO2003055513A2 Bacillus subtilis spores to stimulate the immune responses
07/10/2003WO2003055504A1 Pharmaceutical composition for prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation
07/10/2003WO2003055502A1 Immunoglobulin composition
07/10/2003WO2003027245A3 CONVERSION OF RED BLOOD CELLS A, B, AND AB USING a-N-ACETYLGALACTOSAMINIDASES AND a-GALACTOSIDASE
07/10/2003WO2002086154A3 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages
07/10/2003WO2002074956A3 Dopaminergic neuronal survival-promoting factors and uses thereof
07/10/2003WO2002059278A3 Differentiation of stem cells to pancreatic endocrine cells
07/10/2003WO2002043570A3 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
07/10/2003WO2002012281A3 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
07/10/2003WO2001088096A3 Ovine tissue for xenotransplantation
07/10/2003US20030131365 Genetically engineered animals for use as organ donors
07/10/2003US20030131026 Systems and methods for storing, retrieving, and manipulating data in medical processing devices
07/10/2003US20030130495 G-protein coupled receptors, signal transduction pathways
07/10/2003US20030130338 Method of treatment
07/10/2003US20030130324 Method for preventing or controlling cataract
07/10/2003US20030130218 Methods of stimulating phagocytosis
07/10/2003US20030130216 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease(cad) for treating cardiac disease
07/10/2003US20030130209 Method of treatment of myocardial infarction
07/10/2003US20030130196 Administering angiotensin; antitumor agents; side effect reduction
07/10/2003US20030130194 Process control; antiallergens, autoimmune disease
07/10/2003US20030130192 Administration of leptin
07/10/2003US20030129751 Loading into biocompatible polylactide scaffold and implanting
07/10/2003US20030129750 Inducing vascular growth in tissue via administration of cytokine, chemokine, or chemoattractant; for treatment of cardiac ischemia; tissue engineering
07/10/2003US20030129745 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
07/10/2003US20030129728 Disrupting genes and mixing with plasmids/DNA vaccine; immunology; gene therapy; aging resistance
07/10/2003US20030129645 Can be used as models for the development of human therapeutic targets, aid in the identification of therapeutic proteins, and serve as targets for the development of human therapeutic agents that modulate kinase activity
07/10/2003US20030129583 Testing for the ability of a stealth virus to induce the production of auto-fluorescent material in cells; destroying suspected stealth virus infected cells in a blood sample
07/10/2003US20030129278 Oligosaccharide mixture
07/10/2003US20030129267 Precisely roasting and texturing 100% Kona coffee and adding immediately to pure honey which has been slowly heated to an exact temperature produce skin cleanser and facial mask which can help to smooth and soften skin; antiaging cosmetics
07/10/2003US20030129253 Stable aqueous suspension
07/10/2003US20030129207 Obtaining a biological sample from the patient, contacting the sample with a binding agent that binds to a polypeptide, detecting amount of bounded polypeptide, comparing it to a predetermined cut-off value to determine presence of cancer
07/10/2003US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
07/10/2003US20030129175 Gene therapy; heterogeneity tissue transcription; antitumor agents
07/10/2003US20030129173 Viability and function of pancreatic islets
07/10/2003US20030129172 Animal growth regulator
07/10/2003US20030129167 Enhanced production of blood components, blood cells and plasma without freezing
07/10/2003US20030129166 Human circulating dendritic cell compositions and methods
07/10/2003US20030129079 Method for protein-preserving purification of contaminated biological liquids
07/10/2003CA2511902A1 Seal oil based lipid emulsions and uses thereof
07/10/2003CA2511466A1 Bacillus subtilis spores to stimulate the immune responses
07/10/2003CA2471540A1 A method for the establishment of a pluripotent human blastocyst-derived stem cell line
07/10/2003CA2471306A1 Secreted proteins
1 ... 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 ... 1259